Squalane and the Skin Lipid Ecosystem: The Biomimetic Science Behind the Ingredient

Squalane appears in formulations from The Ordinary to La Mer, yet almost none of the content written about it advances past "gentle and moisturizing." Those descriptors are accurate -- they are also incomplete. The more precise account is a lipid chemistry story: squalane is a C30H62 saturated hydrocarbon comprising approximately 10-12% of human sebum during the second and third decades of life, which means the skin encounters it as a structurally familiar molecule rather than a foreign compound. This article examines the full mechanism -- where squalane sits in the emollient/humectant/occlusive classification framework, how it reduces transepidermal water loss at the intercellular level, and how sugarcane biofermentation replaced deep-sea shark harvesting as the dominant source without any change to the final molecule.

What Squalane Is -- and Why It Is Not Squalene

Squalane (C30H62) is the hydrogenated, stabilized form of squalene, a triterpenoid that accounts for approximately 10-12% of human sebum during youth and declines by up to 60% between the twenties and fifties. The two molecules are related but functionally distinct, and the distinction matters for both formulation science and consumer understanding. Research published in PMC (2018) documents the full biological activity profile of squalene, including its oxidation-driven comedogenic pathway. Squalene -- the precursor, found naturally in sebum -- is an unsaturated hydrocarbon carrying six double bonds in its 30-carbon chain. Those double bonds are reactive sites. Under UV light and atmospheric ozone, squalene oxidizes into peroxides that contribute to comedogenesis, which is one mechanism linking sebum chemistry to inflammatory acne in adult populations. Squalane has had all six double bonds reduced through hydrogenation. The resulting molecule is fully saturated, resistant to oxidation, shelf-stable for multiple years, and free of the peroxidation risk that makes squalene unsuitable for direct topical use.

The practical significance of that saturation is formulation stability. A C30H62 chain with no reactive sites does not compete with antioxidants for free radical neutralization, does not generate aldehydes or peroxides on prolonged storage, and does not change character across the pH range of typical skincare formulations. This chemical inertness is why squalane functions as a reliable carrier and emollient across sensitive, reactive, and compromised skin types where oxidation-prone plant oils frequently cause problems. It also explains why squalane has become a default base for stabilizing oxidation-sensitive actives, including retinol -- The Ordinary's 0.5% Retinol in Squalane is one documented application of this formulation logic.

Where Squalane Sits in the Lipid Barrier Framework

The stratum corneum's intercellular lipid matrix consists of approximately 50% ceramides, 25% cholesterol, and 15% free fatty acids -- the structural mortar between the corneocyte "bricks" of the outermost skin layer. These three lipid classes work in a specific ratio to maintain barrier integrity; when any are depleted through over-exfoliation, aging, or environmental insult, transepidermal water loss increases and skin becomes reactive. Squalane occupies a specific and limited role within this framework: it is an emollient, not a ceramide replacement.

The emollient/humectant/occlusive taxonomy is frequently misapplied in skincare communication, and the misapplication generates poor routine construction. Humectants -- hyaluronic acid, glycerin, panthenol -- are hydrophilic molecules that attract water from the dermis and atmosphere into the stratum corneum. Occlusives -- petrolatum, beeswax, certain silicones -- form a physical film over the skin surface that mechanically slows water evaporation. Squalane does neither. It fills the intercellular lipid gaps in the stratum corneum, integrating into the existing lipid matrix in a way that softens the corneocyte layer and reduces the structural disruptions through which water escapes. This lipid-gap filling mechanism is categorically different from either drawing water inward or sealing the surface. For a side-by-side analysis of squalane versus hyaluronic acid across these mechanisms, the comparison article covers the distinction in detail.

The routine construction implication is straightforward: apply humectant serums before squalane, not after. Applying squalane first would create a lipid layer between the humectant and the skin surface it is designed to reach. The correct sequence -- humectant serum, then emollient -- allows water uptake to complete before the emollient layer integrates into the matrix.

The TEWL Data: What Clinical Application Studies Show

Clinical application studies using standardized Tewameter and corneometry measurement protocols show that topical squalane produces a mean decrease in transepidermal water loss of 1.07 +/- 0.29 g/m2/h, alongside a moisture increase of up to 40% and a surface pH shift of 0.15 units toward a more acidic acid mantle. These are controlled measurements, not marketing estimates, and they provide the quantitative basis for claims about squalane's barrier-support function.

The pH finding carries functional significance that goes beyond the water-retention numbers. The skin's acid mantle, maintained at approximately pH 4.5-5.5 in healthy skin, is essential for two processes: the activity of serine protease enzymes that regulate desquamation (too alkaline and they over-activate, causing flaking), and the regulation of commensal microbiome populations that depend on a specific pH range to outcompete pathogenic organisms. A 0.15-unit shift toward acidity represents improved conditions for these enzyme systems -- not because squalane generates any active chemical reaction, but because improved barrier integrity reduces the alkaline contamination that disrupts surface pH in compromised skin.

For individuals using retinol, the TEWL data provides mechanistic justification for the retinol sandwich technique. Retinol accelerates cell turnover and temporarily depletes intercellular lipids during the 4-6 week retinization period, during which TEWL measurably increases. Applying a thin layer of squalane before the retinol step introduces a lipid-compatible buffer that slows penetration velocity and softens the barrier impact. A second application over the retinol layer supports the lipid matrix through the night. The result is reduced retinization-period irritation without the thick occlusive film that would trap retinol on the surface and increase sensitization risk. For the full retinol layering framework, the retinol and niacinamide layering guide covers sequencing in clinical detail.

Plant-Derived Squalane: The Sugarcane Fermentation Process

Modern squalane production uses Saccharomyces cerevisiae -- the same non-pathogenic yeast used in bread and beer fermentation -- to convert sugarcane-derived sucrose into beta-farnesene, a sesquiterpene hydrocarbon. The beta-farnesene is then dimerized into a C30 chain and hydrogenated to produce squalane. This three-step process yields material that is USDA-certified 100% bio-based, Ecocert-approved, and molecularly identical (C30H62) to squalane purified from shark liver oil or cold-pressed olive derivatives in earlier generations.

The sourcing history matters to formulation chemists for reasons beyond ethics. Squalane extraction from deep-sea shark liver oil varied significantly in purity, with the resulting raw material carrying variable lipid profiles from the surrounding liver tissue that required intensive purification. Olive-derived squalane, a secondary source available since the 1980s, shared similar purity challenges and cost more per unit yield. Sugarcane biofermentation, pioneered commercially by Amyris under the Neossance brand, produces squalane through a controlled fermentation process that generates consistently high-purity output without the variable impurity profile of plant-extracted sources. This consistency matters in sensitive-skin formulations: impurity variation in carrier oils can trigger inflammatory responses that manufacturers cannot predict or replicate across production batches.

The sustainability argument is directly connected to the chemistry. Bonsucro-certified sugarcane, cultivated in coastal Brazil under protocols designed to maintain safe distance from forested regions, provides a renewable feedstock with significantly lower ecological cost than deep-sea harvesting operations. The fermentation process itself generates no persistent environmental pollutants. For an industry that has historically relied on marine and agricultural extraction, sugarcane-fermented squalane represents the first input where the renewable sourcing argument and the purity argument point in the same direction.

Incorporating Squalane: Routine Placement and Barrier Repair Protocols

Squalane's routine role depends on what it is being asked to accomplish. For skin with a functional barrier that simply needs emollience without heaviness -- common in humid climates or for oily skin types experiencing barrier depletion -- squalane applied as the final step after serums provides emollience without the occlusion of a heavier cream. For dry or compromised barrier skin, squalane works most effectively as an intermediate layer beneath a ceramide-containing moisturizer, which supplies the full lipid triad (ceramide, cholesterol, free fatty acid) that squalane alone, as a hydrocarbon, cannot replicate. The ceramide types and barrier function guide covers the triad composition and why ratio matters as much as presence.

For skin recovering from over-exfoliation, sensitization reactions, or contact dermatitis, a simplified protocol -- gentle cleanser, squalane, SPF -- can provide sufficient barrier support while the inflammatory response resolves, before reintroducing actives. This "minimum viable routine" approach works because squalane's chemical inertness means it will not interact adversely with healing tissue, and its lipid-gap filling function addresses the primary mechanism of barrier compromise without adding further chemical load to irritated skin.

Squalane's compatibility with nearly every active ingredient category -- retinoids, AHAs, vitamin C, niacinamide, peptides -- makes it one of the few emollients that does not require reformulation consideration when a routine changes. It does not affect pH-sensitive actives, does not chelate metals that some actives require, and does not accelerate or inhibit the oxidation of neighboring molecules. In practice, this means squalane can remain in a routine across multiple iterations without becoming a variable that needs to be reconsidered.

Squalane's appeal is not cosmetic convenience -- it is biochemical specificity. Skin synthesizes squalene as a component of its own sebum; topically applied squalane provides the stabilized, oxidation-resistant version of that same molecular class, filling lipid gaps that aging, environmental exposure, and active ingredient use progressively create. The clinical data on TEWL reduction is modest in absolute terms but consistent across skin types, and the tolerability profile reflects mechanism rather than marketing. For routine construction: apply after humectants, before ceramide-rich moisturizers, and alongside retinol for barrier support during the retinization period. Sugarcane-derived versions are chemically equivalent to earlier generations -- and far less costly to the deep-sea ecosystem.